SERB

SERB is a specialty pharmaceuticals group in Europe, dedicated to prescription drugs for the treatment of rare and life-threatening diseases. Through strategic acquisitions and targeted development, SERB has successfully built a stable portfolio of niche specialty drugs to maintain the availability of life-saving medications and meet unmet medical needs. Their commitment is to continue providing essential drugs that address public health demands.